TY - JOUR
T1 - Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations
AU - Lambert, Jean Charles
AU - Zelenika, Diana
AU - Hiltunen, Mikko
AU - Chouraki, Vincent
AU - Combarros, Onofre
AU - Bullido, Maria J.
AU - Tognoni, Gloria
AU - Fiévet, Nathalie
AU - Boland, Anne
AU - Arosio, Beatrice
AU - Coto, Eliecer
AU - Zompo, Maria Del
AU - Mateo, Ignacio
AU - Frank-Garcia, Ana
AU - Helisalmi, Seppo
AU - Porcellini, Elisa
AU - Pilotto, Alberto
AU - Forti, Paola
AU - Ferri, Raffaele
AU - Delepine, Marc
AU - Scarpini, Elio
AU - Siciliano, Gabriele
AU - Solfrizzi, Vincenzo
AU - Sorbi, Sandro
AU - Spalletta, Gianfranco
AU - Ravaglia, Giovanni
AU - Valdivieso, Fernando
AU - Alvarez, Victoria
AU - Bosco, Paolo
AU - Mancuso, Michelangelo
AU - Panza, Francesco
AU - Nacmias, Benedetta
AU - Bossu, Paola
AU - Piccardi, Paola
AU - Annoni, Giorgio
AU - Seripa, Davide
AU - Galimberti, Daniela
AU - Licastro, Federico
AU - Lathrop, Mark
AU - Soininen, Hilkka
AU - Amouyel, Philippe
PY - 2011/4
Y1 - 2011/4
N2 - Recent genome-wide association studies have identified 5 loci (BIN1, CLU, CR1, EXOC3L2, and PICALM) as genetic determinants of Alzheimer's disease (AD). We attempted to confirm the association between these genes and the AD risk in 3 contrasting European populations (from Finland, Italy, and Spain). Because CLU and CR1 had already been analyzed in these populations, we restricted our investigation to BIN1, EXO2CL3, and PICALM. In a total of 2816 AD cases and 2706 controls, we unambiguously replicated the association of rs744373 (for BIN1) and rs541458 (for PICALM) polymorphisms with the AD risk (odds ratio [OR] = 1.26, 95% confidence interval [CI] [1.15-1.38], p = 2.9 × 10-7, and OR = 0.80, 95% CI [0.74-0.88], p = 4.6 × 10-7, respectively). In a meta-analysis, rs597668 (EXOC3L2) was also associated with the AD risk, albeit to a lesser extent (OR = 1.19, 95% CI [1.06-1.32], p = 2.0 × 10-3). However, this signal did not appear to be independent of APOE. In conclusion, we confirmed that BIN1 and PICALM are genetic determinants of AD, whereas the potential involvement of EXOC3L2 requires further investigation.
AB - Recent genome-wide association studies have identified 5 loci (BIN1, CLU, CR1, EXOC3L2, and PICALM) as genetic determinants of Alzheimer's disease (AD). We attempted to confirm the association between these genes and the AD risk in 3 contrasting European populations (from Finland, Italy, and Spain). Because CLU and CR1 had already been analyzed in these populations, we restricted our investigation to BIN1, EXO2CL3, and PICALM. In a total of 2816 AD cases and 2706 controls, we unambiguously replicated the association of rs744373 (for BIN1) and rs541458 (for PICALM) polymorphisms with the AD risk (odds ratio [OR] = 1.26, 95% confidence interval [CI] [1.15-1.38], p = 2.9 × 10-7, and OR = 0.80, 95% CI [0.74-0.88], p = 4.6 × 10-7, respectively). In a meta-analysis, rs597668 (EXOC3L2) was also associated with the AD risk, albeit to a lesser extent (OR = 1.19, 95% CI [1.06-1.32], p = 2.0 × 10-3). However, this signal did not appear to be independent of APOE. In conclusion, we confirmed that BIN1 and PICALM are genetic determinants of AD, whereas the potential involvement of EXOC3L2 requires further investigation.
KW - Alzheimer
KW - APOE
KW - Association
KW - BIN1
KW - EXOC3L2
KW - GWA
KW - PICALM
KW - Polymorphism
KW - Risk
UR - http://www.scopus.com/inward/record.url?scp=79953032765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953032765&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2010.11.022
DO - 10.1016/j.neurobiolaging.2010.11.022
M3 - Article
C2 - 21220176
AN - SCOPUS:79953032765
SN - 0197-4580
VL - 32
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 4
ER -